UBS Group’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $26.9M | Buy |
1,153,662
+437,443
| +61% | +$9.5M | ﹤0.01% | 2267 |
|
|
2025
Q4 | $15M | Sell |
716,219
-958,294
| -57% | -$16.7M | ﹤0.01% | 2874 |
|
|
2025
Q3 | $25.8M | Buy |
1,674,513
+239,098
| +17% | +$3.13M | ﹤0.01% | 2288 |
|
|
2025
Q2 | $13.4M | Sell |
1,435,415
-280,363
| -16% | -$3.09M | ﹤0.01% | 2798 |
|
|
2025
Q1 | $21.1M | Buy |
1,715,778
+686,957
| +67% | +$9.69M | ﹤0.01% | 2269 |
|
|
2024
Q4 | $13.6M | Buy |
1,028,821
+882,383
| +603% | +$15.1M | ﹤0.01% | 2735 |
|
|
2024
Q3 | $2.82M | Buy |
146,438
+21,286
| +17% | +$440K | ﹤0.01% | 3664 |
|
|
2024
Q2 | $2.57M | Sell |
125,152
-144,659
| -54% | -$3.03M | ﹤0.01% | 3506 |
|
|
2024
Q1 | $6.42M | Sell |
269,811
-20,990
| -7% | -$468K | ﹤0.01% | 2705 |
|
|
2023
Q4 | $6.28M | Buy |
290,801
+215,444
| +286% | +$3.31M | ﹤0.01% | 2525 |
|
|
2023
Q3 | $1.09M | Sell |
75,357
-37,359
| -33% | -$707K | ﹤0.01% | 3986 |
|
|
2023
Q2 | $2.36M | Buy |
112,716
+4,401
| +4% | +$91.6K | ﹤0.01% | 3366 |
|
|
2023
Q1 | $2.29M | Sell |
108,315
-64,470
| -37% | -$1.6M | ﹤0.01% | 3276 |
|
|
2022
Q4 | $4.4M | Sell |
172,785
-112,747
| -39% | -$2.63M | ﹤0.01% | 2625 |
|
|
2022
Q3 | $6.86M | Sell |
285,532
-31,143
| -10% | -$699K | ﹤0.01% | 2090 |
|
|
2022
Q2 | $6.09M | Buy |
316,675
+101,511
| +47% | +$1.69M | ﹤0.01% | 2213 |
|
|
2022
Q1 | $3.74M | Buy |
215,164
+74,647
| +53% | +$1.26M | ﹤0.01% | 2828 |
|
|
2021
Q4 | $3.08M | Buy |
140,517
+70,004
| +99% | +$1.29M | ﹤0.01% | 3328 |
|
|
2021
Q3 | $1.35M | Buy |
70,513
+52,141
| +284% | +$869K | ﹤0.01% | 3925 |
|
|
2021
Q2 | $315K | Sell |
18,372
-45,000
| -71% | -$824K | ﹤0.01% | 5051 |
|
|
2021
Q1 | $1.42M | Buy |
63,372
+51,708
| +443% | +$1.17M | ﹤0.01% | 3900 |
|
|
2020
Q4 | $260K | Buy |
11,664
+10,664
| +1,066% | +$221K | ﹤0.01% | 5073 |
|
|
2020
Q3 | $15K | Sell |
1,000
-29,063
| -97% | -$443K | ﹤0.01% | 6532 |
|
|
2020
Q2 | $446K | Buy |
30,063
+14,186
| +89% | +$216K | ﹤0.01% | 4240 |
|
|
2020
Q1 | $174K | Sell |
15,877
-9,918
| -38% | -$93.1K | ﹤0.01% | 4830 |
|
|
2019
Q4 | $227K | Buy |
25,795
+3,990
| +18% | +$29.3K | ﹤0.01% | 5523 |
|
|
2019
Q3 | $163K | Buy |
21,805
+16,136
| +285% | +$147K | ﹤0.01% | 5410 |
|
|
2019
Q2 | $53K | Buy |
5,669
+3,669
| +183% | +$26.7K | ﹤0.01% | 5876 |
|
|
2019
Q1 | $11K | Sell |
2,000
-8,469
| -81% | -$48.3K | ﹤0.01% | 6757 |
|
|
2018
Q4 | $47K | Buy |
10,469
+7,323
| +233% | +$40.1K | ﹤0.01% | 6143 |
|
|
2018
Q3 | $25K | Buy |
3,146
+1,146
| +57% | +$8.17K | ﹤0.01% | 6673 |
|
|
2018
Q2 | $14K | Sell |
2,000
-1,371
| -41% | -$13.5K | ﹤0.01% | 6948 |
|
|
2018
Q1 | $48K | Buy |
3,371
+1,371
| +69% | +$14.6K | ﹤0.01% | 5743 |
|
|
2017
Q4 | $18K | Sell |
2,000
-362
| -15% | -$3.58K | ﹤0.01% | 6634 |
|
|
2017
Q3 | $27K | Buy |
2,362
+1,821
| +337% | +$22.3K | ﹤0.01% | 6246 |
|
|
2017
Q2 | $8K | Sell |
541
-932
| -63% | -$10.7K | ﹤0.01% | 6922 |
|
|
2017
Q1 | $20K | Buy |
1,473
+665
| +82% | +$6.91K | ﹤0.01% | 6145 |
|
|
2016
Q4 | $6K | Sell |
808
-8,189
| -91% | -$89.7K | ﹤0.01% | 7165 |
|
|
2016
Q3 | $136K | Buy |
8,997
+8,126
| +933% | +$107K | ﹤0.01% | 4799 |
|
|
2016
Q2 | $9K | Buy |
+871
| New | +$11.9K | ﹤0.01% | 6845 |
|
Other funds holding SNDX
KCM
VCM
DM
EP
KCM
HRCM